| Title: | United States top 40 anti-infective agents by sales, sales change, number of prescriptions, change in number of prescriptions, advertising expenditures and change in advertising expenditures in dollars and percentages for 2010 |
|---|---|
| Source: | Medical Marketing & Media |
| Date: | Aug 2011 |
| Price: | $20.00 |
| Categories: |
Start of full article - but without data
Table
TOP XX INFECTOUS DISEASE PRODUCTS, 2010
Categoty leaders, ranked by 2010 US sales, and their media spend
Rank Product Manufacturer US sales dollars %
(millions) * change
vs.
prior
XX
mos.
X Atripla BMS/Gilead $X,XXX.X XX.X%
X Levaquin Johnson & $X,XXX.X -X.X%
Johnson
X Truvada Gilead $X,XXX.X XX.X%
X Azithromycin Generic $X,XXX.X -X.X%
X Zosyn Pfizer $XXX.X -X.X%
X Reyataz Bristol-Myers $XXX.X([dagger]) X.X%
Squibb
X Solodyn Medicis $XXX.X XX.X%
X Amoxicillin Generic $XXX.X -X.X%
tr./clavulanate
X Zyvox Pfizer $XXX.X -X.X%
XX Prevnar XX Pfizer $XXX.X N/A
XX Ciprofloxacin Generic $XXX.X X.X%
HCI
XX Isentress Merck $XXX.X XX.X%
XX Pegasys Roche $XXX.X X.X%
XX Norvir Abbott $XXX.X XX.X%
XX Cubicin Cubist $XXX.X X.X%
XX Prezista Johnson & $XXX.X XX.X%
Johnson
XX Epzicom ViiV Healthcare $XXX.X XX.X%
XX Kaletra Abbott $XXX.X -XX.X%
XX Cefdinir Generic $XXX.X -X.X%
XX Avelox Bayer $XXX.X -XX.X%
HealthCare
XX Doryx Warner Chilcott $XXX.X XX.X%
XX Viread Gilead $XXX.X XX.X%
XX Amoxicillin Generic $XXX.X X.X%
XX Combivir ViiV Healthcare $XXX.X -X.X%
XX Vancomycin HCI Generic $XXX.X X.X%
XX Vancocin HCI ViroPharma $XXX.X XX.X%
XX Cephalexin Generic $XXX.X X.X%
XX Engerix-B GlaxoSmithKline $XXX.X X.X%
XX Fluvirin Novartis $XXX.X XX.X%
XX Oracea Galderma $XXX.X XX.X%
XX Tobi Novartis $XXX.X X.X%
XX Minocycline HCI Generic $XXX.X -X.X%
XX Co-trimoxazole Generic $XXX.X X.X%
XX Invanz Merck $XXX.X XX.X%
XX Sustiva Bristol-Myers $XXX.X -XX.X%
Squibb
XX Clindamycin HCI Generic $XXX.X X.X%
XX Pneumovax XX Merck $XXX.X XX.X%
XX Primaxin Merck $XXX.X -X.X%
XX Merrem AstraZeneca $XXX.X -XX.X%
XX Tygacil Pfizer $XXX.X -X.X%
...
